Polivy (polatuzumab vedotin) 140 mg powder for concentrate for solution for injection: Important information on plastic vial flip-off cap colour

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Polivy
Active substance
polatuzumab vedotin
Therapeutic area (MeSH)
Lymphoma, B-Cell
Procedure number
EMEA/H/C/004870
DHPC type
Quality defect
Human ATC code
L01XC

How useful was this page?

Add your rating